Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,081 | N/A | -1,884 | N/A | -547 |
| Depreciation Amortization | 1,232 | N/A | 148 | N/A | 16 |
| Accounts receivable | N/A | N/A | N/A | N/A | -199 |
| Accounts payable and accrued liabilities | -217 | N/A | 375 | N/A | 62 |
| Other Working Capital | -247 | N/A | 579 | N/A | 165 |
| Other Operating Activity | 32,758 | 0 | -176 | 0 | 192 |
| Operating Cash Flow | $-3,556 | $N/A | $-959 | $N/A | $-312 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | N/A | -16 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -65 | N/A | N/A |
| Other Investing Activity | -38 | 0 | -65 | 0 | 0 |
| Investing Cash Flow | $-44 | $N/A | $-81 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,268 | N/A | 160 |
| Common Stock Issued | 13,723 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -110 | 0 | -456 | 0 | -26 |
| Financing Cash Flow | $13,612 | $N/A | $812 | $N/A | $134 |
| Beginning Cash Position | 340 | N/A | 285 | N/A | 285 |
| End Cash Position | 10,353 | N/A | 57 | N/A | 108 |
| Net Cash Flow | $10,013 | $N/A | $-229 | $N/A | $-178 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,556 | N/A | -959 | N/A | -312 |
| Capital Expenditure | -6 | N/A | -16 | N/A | N/A |
| Free Cash Flow | -3,561 | 0 | -975 | 0 | -312 |